##
##
##
|||||Page|
|---|---|---|---|---|
|Trustees'
Annual
Report (Incorporating
the||Director's Report)|||
|independent
Examiner's
Report|to the Trustees||||
|Statement ofFinancial Activities|(Including|Income and Expenditure|Account)||
|Statement ofFinancial
Position|||||
|Notes to the Financial Statements||||10|
|The Following
Pages Do Not|Form Part|ofthe Financial Statements|||
|Detailed Statement
ofFinancial|Activities|||18|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|Refe e|e|and Administrative|and Administrative|and Administrative|and Administrative|Det|||||
|---|---|---|---|---|---|---|---|---|---|---|
|Registered|||charity name|||Citizens Advice Cumbria|||||
|Charity registration||||number||1079229 "' i.
P|||||
|Company||registration|||number|03865647|||||
|Principal|oNce and|||registered||C/o Citizens Advice Carlisle and Eden||Office|||
|oNce||||||2 Sandgate|||||
|||||||Penrith|||||
|||||||Cumbria|||||
|||||||CA11 7TP|||||
|The Trustees|||||||||||
|||||||J Whitehead
Citizens Advice South Lakes (Chair)|||||
|||||||G P Smith Citizens Advice Copeland|(Treasurer)||||
|||||||J A Auld Citizens Advice Carlisie & Eden|||||
|||||||A CSpence Citizens Advice Cartisle &||Eden (Resigned||1 May|
|||||||2022)|||||
|||||||T M Telford Citizens Advice Allerdale|(Resigned 31||October 2022)||
|||||||D Shepherd
Citizens Advice Carlisle &||Eden|||
|||||||M C McKinlay Citizens Advice Barrow||In Fumess|||
|||||||JWhitehead
Citizens Advice South Lakes (Chair)|||||
|||||||K Evans Citizens Advice South Lakes|||||
|||||||KA Little Citizens Advice Allerdale|||||
|||||||W Robinson Citizens Advice Barrow In||Fumess|||
|||||||S Hewitson
Citizens Advice Copeland|||||
|||||||T F Edwards
Citizens Advice Copeland||(Appointed|1 July 2022)||
|Company||Secretary||||WJ Robinson|||||
|Independent|||Examiner|||Jane Ascroft FCA MA (Cantab)|||||
|||||||Enterprise
House|||||
|||||||Harmire
Enterprise
Park|||||
|||||||Bamard Castle|||||
|||||||County
Durham|||||
|||||||DL12 SXT|||||
##
##
##
##
##
##
##
##
##
##
|||||2023||2022|
|---|---|---|---|---|---|---|
||||Unrestricted|Restricted|||
||||funds|funds|Total funds|Total funds|
|||Note|R||R||
|Income and endowments|||||||
|Donations
and legacies||||||856|
|Charitable
activities||||206,011|206,011|201,500|
|Investment
income|||135||135|1|
|Total income|||135|206,011|206,146|202,357|
|Expenditure|||||||
|Expenditure
on charitable|activities|8,9|3,865|203,839|207,704|209,087|
|Total expenditure|||3,865|203,839|207,704|209,087|
|Net expenditure|||(3,730)|2,172|(1,558)|(6,730)|
|Transfers between funds|||2,172|(2,172)|||
|Net movement
in funds|||(1,558)||(1,558)|(6,730)|
|Reconciliation
offunds|||||||
|Total funds brought forward|||28,610||28,610|35,340|
|Total funds carried forward|||27,052||27,052|28,610|
##
##
##
|||||2023|2022|
|---|---|---|---|---|---|
|||||R||
|Current Assets||||||
|Debtors||||17,377|47,101|
|Cash at bank and in hand||||27,440|9,154|
|||||44,817|56,255|
|Creditors: amounts|falling|due within one year|16|17,765|27,645|
|Net Current Assets||||27,052|28,610|
|Total Assets Less Current||Llabllltles||27,052|28,610|
|Net Assets||||27,052|28,610|
|Funds ofthe Charity||||||
|Unrestricted
funds||||27,052|28,610|
|Total charity funds|||17|27,052|28,610|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|5.|had undertak
Donations|en
to contribute
and Legacies|an amount
not exceeding|F1 in the even|t ofa winding|up.|
|---|---|---|---|---|---|---|
||||Unrestricted|Total Funds|Unrestricted|Total Funds|
||||Funds|2023|Funds|2022|
|||||||F|
||Donations||||||
||Donations||||856|856|
|6.|Charitable|Activities|||||
||||Restricted|Total Funds|Restricted|Total Funds|
||||Funds|2023|Funds|2022|
||||F|R|E||
||Macmillan Cancer Support||206,011|206,011|201,500|201,500|
|7.|Investment|Income|||||
||||Unrestricted|Total Funds|Unrestricted|Total Funds|
||||Funds|2023|Funds|2022|
|||||R|||
||Bank interest||135|135||1|
|8.|Expenditure|on Charitable|Activities by Fund Type||||
|||||Unrestricted|Restricted|Total Funds|
|||||Funds|Funds|2023|
|||||E|E||
||Macmillan Cancer Support||||203,839|203,839|
||Support costs|||3,865||3,865|
|||||3,865|203,839|207,704|
|||||Unrestricted|Restricted|Total Funds|
|||||Funds|Funds|2022|
||Macmillan Cancer Support||||199,289|199,289|
||Support costs|||9,798||9,798|
|||||9,798|199,289|209,087|
##
##
|9.|Expenditure|on Charitabl|e
Activ|ities by Activity Type||||
|---|---|---|---|---|---|---|---|
|||||Activities||||
|||||undertaken||Total funds|Total fund|
|||||directly Support costs||2023|2022|
|||||F||||
||Macmillan Cancer Support|||203,839||203,839|199,289|
||Support costs and governance||||3,865|3,865|9,798|
|||||203,839|3,865|207,704|209,087|
|10.|Independent|Examination|Fees|||||
|||||||2023|2022|
||Fees payable|to the independent||examiner for.||||
||Independent|examination|ofthe financial statements|||780||
##
##
##
##
##
|
totalling
R2,172 in relation to a set percentage
management
f
Tangible Fixed Assets|
ee.|
|---|---|
||Equipment|
|Cost||
|At 1April 2022 and 31 Nlarch 2023|1,364|
|Depreciation||
|At 1April 2022 and 31 March 2023|1,364|
|Carrying
amount||
|At 31March 2023||
|At 31 March 2022||
##
##
##
|15.|Debtors||||||
|---|---|---|---|---|---|---|
||||||2023|2022|
|||||||f|
||Macmillan|debtor|||17,377|47,101|
|16.|Creditors:|amounts|falling|due within one year|||
||||||2023|2022|
||||||E||
||Accruals and deferred||income||780|720|
||Macmillan|partner payments||owed to local CitA offices|16,985|26,925|
||||||17,765|27,645|
##
|||At||||At 31|Ilarch|
|---|---|---|---|---|---|---|---|
|||1 April 2022|Income|Expenditure|Transfers||2023|
|General funds||14,610|135|(3,865)|2,172||13,052|
|Designated|Funds|14,000|||||14,000|
|||28,610|135|(3,865)|2,172||27,052|
|||At||||At 31|March|
|||1 April 2021|Income|Expenditure
F|Transfers||2022
f|
|General funds||21,340|857|(9,798)|2,211||14,610|
|Designated|Funds|14,000|||||14,000|
|||35,340|857||2,211||28,610|
##
##
##
##
|Restricted|funds||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|||||At||||At|31|March|
|||1|April|2022|Income|Expenditure|Transfers|||2023|
|MacMillan|Cancer||||||||||
|Support|||||206,011|(203,839)|(2,172)||||
|||||At||||At|31|March|
|||1|April|2021|Income|Expenditure|Transfers|||2022|
|MacMillan|Cancer||||||||||
|Support|||||201,500|(199,289)|(2,211)||||
##
|Analysis of Net Assets Between Funds|||
|---|---|---|
||Unrestricted|Total Funds|
||Funds|2023|
|Current assets|44,817|44,817|
|Creditors less than 1 year|(17,765)|(17,765)|
|Net assets|27,052|27,052|
||Unrestricted|Total Funds|
||Funds|2022|
|Current assets|56,255|56,255|
|Creditors less than 1 year|(27,645)|(27,645)|
|Net assets|28,610|28,610|
##
##
##
##
##
|||||2023|2022|
|---|---|---|---|---|---|
|Income and endowments||||||
|Donations
and legacies||||||
|Donations||||||
|Charitable
activities||||||
|Macmillan
Cancer|Support|||206,011|201,500|
|Investment
income||||||
|Bank interest||||135||
|Total income||||206,146|202,357|
|Expenditure||||||
|ActNi5es undertaken||directly||||
|Partner payments|to local||CitA offices - Macmillan|203,839|199,289|
|Support costs||||||
|Insurance||||177|176|
|Independent
Examination|||fees|816|720|
|Training costs||||2,700|7,900|
|Donation
made to|Local Citizens Advice||||856|
|Other costs||||172|146|
|||||3,865|9,798|
|Total expenditure||||207,704|209,087|
|Net expenditure||||(1,556)|(6,730)|